Deetech Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.80 M
- Company Age 27 Year, 2 Months
- Last Filing with ROC 31 Mar 2010
- Open Charges ₹ 0.70 M
About Deetech Pharmaceuticals
Deetech Pharmaceuticals Private Limited (DPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 November 1997 and has a history of 27 years and two months. Its registered office is in Delhi, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2010. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.80 M.
The company currently has active open charges totaling ₹0.70 M.
Archna Mishra and Daya Mishra serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999DL1997PTC090789
-
Company No.
090789
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Nov 1997
-
Date of AGM
30 Sep 2010
-
Date of Balance Sheet
31 Mar 2010
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Deetech Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Archna Mishra
|
Director | 20-Nov-1997 | Current |
|
Daya Mishra
|
Director | 20-Nov-1997 | Current |
Financial Performance of Deetech Pharmaceuticals.
Enhance accessibility to Deetech Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Deetech Pharmaceuticals?
Unlock access to Deetech Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Srm Mahaadeo Smart Bio-Toilets Private LimitedDaya Mishra is a mutual person
-
Mcf Project Management Private Limited
Daya Mishra is a mutual person
-
Gcm Buildtech India Private Limited
Daya Mishra is a mutual person
-
Social Justice Foundation
Daya Mishra is a mutual person
Charges (Loans)
₹0.70 M
₹0
Charges Breakdown by Lending Institutions
- Oriental Bank Of Commerce : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Dec 2001 | Oriental Bank Of Commerce | ₹0.70 M | Open |
How Many Employees Work at Deetech Pharmaceuticals?
Unlock and access historical data on people associated with Deetech Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Deetech Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deetech Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.